Sort
261,768 grants matching “gene therapy”
Vaccines and Therapeutics for Anthrax
$1,079,233Stephen H Leppla · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease
$1,079,215Jay Williams Hooper · Geneva Foundation · R01 · FY2019 · AI
Determinants of inception of inflammation in inflammatory bowel diseases
$1,079,167Ashwin N Ananthakrishnan · Massachusetts General Hospital · R01 · FY2023 · DK
B-CELL TARGETED INDUCTION TO IMPROVE OUTCOMES IN PEDIATRIC LUNG TRANSPLANTATION
$1,079,038Stuart C Sweet · Washington University · U01 · FY2017 · AI
Prenatal Treatment of Down Syndrome to Improve Brain Development and Neurocognition
$1,078,790Diana Bianchi · National Human Genome Research Institute · ZIA · FY2018 · HG
Whole blood filter paper assay for Alzheimers Disease
$1,078,739Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2024 · AG
Molecular Cytogenetics of Solid Tumors
$1,078,567Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Cancer Genomics: Integrative and Scalable Solutions in R/Bioconductor
$1,078,506Levi Waldron · Graduate School Of Public Health And Health Policy · U24 · FY2025 · CA
Genetics of Alzheimer's Disease in Israeli Arabs
$1,078,448Robert Paul Friedland · University Of Louisville · R01 · FY2009 · AG
A novel, pleiotropic oral drug class that inhibits gut migration of activated T cells
$1,078,081Scott McNear Thacher · Orphagen Pharmaceuticals · R44 · FY2024 · DK
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,078,057Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2014 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,077,894Thomas R Hawn · University Of Washington · R61 · FY2018 · AI
Biological and lifestyle factors contributing to Tau in women at risk for Alzheimer's disease.
$1,077,862Sarah Banks · University Of California, San Diego · R01 · FY2024 · AG
HyperGEN: Genetics of Left Ventricular Hypertrophy
$1,077,617Donna K. Arnett · University Of Kentucky · R01 · FY2016 · HL
Preparation and Distribution of Adult Stem Cells
$1,077,610Darwin Johnson Prockop · Texas A&M University Health Science Ctr · P40 · FY2010 · RR
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
$1,077,600Neal Rosen · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA
Isolation, characterization and translational development of glioma stem cells
$1,077,600Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Isolation, characterization and translational development of glioma stem cells
$1,077,600Luis F Parada · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
$1,077,600Neal Rosen · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Development of a novel disease modifying oral therapy for pulmonary arterial hypertension.
$1,077,584Jaipal Singh · Vasculonics, Llc · R44 · FY2024 · HL
Clinical development of mechanism-based lymphoma therapies
$1,077,450Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Rehabilitation Medicine Scientist Training (RMST) Program
$1,077,064Michael L Boninger · University Of Pittsburgh At Pittsburgh · K12 · FY2008 · HD
Identifying the mechanisms of leukemia progression
$1,077,000John D Crispino · St. Jude Children'S Research Hospital · R35 · FY2025 · CA
Identifying the mechanisms of leukemia progression
$1,077,000John D Crispino · St. Jude Children'S Research Hospital · R35 · FY2021 · CA
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,077,000Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2021 · CA